# Zedge, Inc.: overview ZDGE · NYSE · CIK 1667313 · [Technology](/sectors/technology.md) · fiscal year ends Jul 31 Pages: [Overview](/companies/zdge.md) · [Financials](/companies/zdge/financials.md) · [Filings](/companies/zdge/filings.md) · [Insiders](/companies/zdge/insiders.md) Latest reported revenue: [$7.8m](/filings/0001213900-26-113312.md) for Q4 FY2026, three months to 2026-07-31, from the 10-K filed Oct 28, 2026 (XBRL us-gaap:Revenues, accession 0001213900-26-113312). ## Last eight quarters | Line item | Unit | Q1 FY2025 (2024-10-31) | Q2 FY2025 (2025-01-31) | Q3 FY2025 (2025-04-30) | Q4 FY2025 (2025-07-31) | Q1 FY2026 (2025-10-31) | Q2 FY2026 (2026-01-31) | Q3 FY2026 (2026-04-30) | Q4 FY2026 (2026-07-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [7,194](/filings/0001213900-25-121203.md) | [6,979](/filings/0001213900-26-028295.md) | [7,757](/filings/0001213900-26-068278.md) | [7,468 d](/filings/0001213900-26-113312.md) | [7,610](/filings/0001213900-25-121203.md) | [8,254](/filings/0001213900-26-028295.md) | [7,992](/filings/0001213900-26-068278.md) | [7,770 d](/filings/0001213900-26-113312.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(6.4%)](/filings/0001213900-25-121203.md) | [(31.8%)](/filings/0001213900-26-028295.md) | [2.1%](/filings/0001213900-26-068278.md) | [(9.6%) d](/filings/0001213900-26-113312.md) | [12.0%](/filings/0001213900-25-121203.md) | [(35.0%)](/filings/0001213900-26-028295.md) | [13.4%](/filings/0001213900-26-068278.md) | [3.3% d](/filings/0001213900-26-113312.md) | | Net margin | % | [(4.7%)](/filings/0001213900-26-068278.md) | [(24.1%)](/filings/0001213900-26-068278.md) | [2.4%](/filings/0001213900-26-068278.md) | [(7.5%) d](/filings/0001213900-26-113312.md) | [10.4%](/filings/0001213900-26-068278.md) | [(27.7%)](/filings/0001213900-26-068278.md) | [11.6%](/filings/0001213900-26-068278.md) | [5.7% d](/filings/0001213900-26-113312.md) | | Diluted EPS | $ per share | [(0.02)](/filings/0001213900-25-121203.md) | [(0.12)](/filings/0001213900-26-028295.md) | [0.01](/filings/0001213900-26-068278.md) | not reported | [0.06](/filings/0001213900-25-121203.md) | [(0.18)](/filings/0001213900-26-028295.md) | [0.07](/filings/0001213900-26-068278.md) | not reported | | Free cash flow | $k | [1,159](/filings/0001213900-25-121203.md) | [689 d](/filings/0001213900-26-028295.md) | [851 d](/filings/0001213900-26-068278.md) | [640 d](/filings/0001213900-26-113312.md) | [808](/filings/0001213900-25-121203.md) | [855 d](/filings/0001213900-26-028295.md) | [1,215 d](/filings/0001213900-26-068278.md) | [1,650 d](/filings/0001213900-26-113312.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure. ## Last five fiscal years | Line item | Unit | FY2022 (2022-07-31) | FY2023 (2023-07-31) | FY2024 (2024-07-31) | FY2025 (2025-07-31) | FY2026 (2026-07-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [26.5](/filings/0001213900-23-081544.md) | [27.2](/filings/0001213900-24-091735.md) | [30.1](/filings/0001213900-25-103098.md) | [29.4](/filings/0001213900-26-113312.md) | [31.6](/filings/0001213900-26-113312.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [44.6%](/filings/0001213900-23-081544.md) | [(25.4%)](/filings/0001213900-24-091735.md) | [(39.2%)](/filings/0001213900-25-103098.md) | [(11.0%)](/filings/0001213900-26-113312.md) | [(2.0%)](/filings/0001213900-26-113312.md) | | Net margin | % | [36.6%](/filings/0001213900-23-081544.md) | [(22.4%)](/filings/0001213900-24-091735.md) | [(30.5%)](/filings/0001213900-25-103098.md) | [(8.1%)](/filings/0001213900-26-113312.md) | [(0.4%)](/filings/0001213900-26-113312.md) | | Diluted EPS | $ per share | [0.65](/filings/0001213900-23-081544.md) | [(0.43)](/filings/0001213900-24-091735.md) | [(0.65)](/filings/0001213900-25-103098.md) | [(0.17)](/filings/0001213900-26-113312.md) | [(0.01)](/filings/0001213900-26-113312.md) | | Free cash flow | $m | [11.4](/filings/0001213900-23-081544.md) | [3.1](/filings/0001213900-24-091735.md) | [5.8](/filings/0001213900-25-103098.md) | [3.3](/filings/0001213900-26-113312.md) | [4.5](/filings/0001213900-26-113312.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/zdge/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $1.6m | 532,222 | | Added +17,273 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.6m | 519,339 | | Reduced −37,054 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $421.9k | 136,088 | | New +136,088 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $361.6k | 116,616 | | Reduced −34,429 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $314.7k | 101,532 | | Unchanged | | [KAHN BROTHERS GROUP INC](/funds/1039565.md) | 2026-06-30 | $242.2k | 78,126 | | Added +198 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $230.3k | 74,300 | Put | Added +61,500 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $225.0k | 72,588 | | Added +12,449 | | [Bank of New York Mellon Corp](/funds/1390777.md) | 2026-06-30 | $196.0k | 63,239 | | Unchanged | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $175.8k | 56,700 | | New +56,700 | ## Recent filings [All 402 filings](/companies/zdge/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-29 | 16:10 ET | [8-K](/filings/0001213900-26-113804.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-113804 | | 2026-10-28 | 16:10 ET | [10-K](/filings/0001213900-26-113312.md) | Annual report, period 2026-07-31 | 0001213900-26-113312 | | 2026-10-26 | 16:11 ET | [8-K](/filings/0001213900-26-112482.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-112482 | | 2026-10-21 | 08:02 ET | [8-K](/filings/0001213900-26-111195.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-111195 | | 2026-10-19 | 13:27 ET | [8-K](/filings/0001213900-26-110602.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-110602 | | 2026-10-09 | 10:32 ET | [8-K](/filings/0001213900-26-108282.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-108282 | | 2026-10-02 | 06:30 ET | [SCHEDULE 13D](/filings/0001213900-26-106074.md) | Ownership report, active investor | 0001213900-26-106074 | | 2026-09-30 | 06:38 ET | [8-K/A](/filings/0001213900-26-104861.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-104861 | | 2026-09-10 | 16:30 ET | [8-K](/filings/0001213900-26-098816.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-098816 | | 2026-09-10 | 16:30 ET | [SCHEDULE 13D/A](/filings/0001213900-26-098817.md) | Ownership report, active investor, amended | 0001213900-26-098817 | ## Latest annual report [Form 10-K for the fiscal year ended Jul 31, 2026](/filings/0001213900-26-113312.md), filed Oct 28, 2026. ## Forecast league Q4 FY2026, the quarter ended 2026-07-31, has been scored from the reported figures. [See the target](/leagues/2026q3/targets/3026d363-c4d2-4f71-afb0-387eb263de7d) ## About the filer - CIK: 1667313 - Tickers: ZDGE - Exchange: NYSE - SIC code: 7372 Services-Prepackaged Software - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 12:49 ET. No prices; not investment advice.